DTAT is a methodologic framework allowing dose individualization to be
conceived as a continuous learning process that begins in early-phase
clinical trials and continues throughout drug development, on into
clinical practice. This package includes code that researchers may use
to reproduce or extend key results of the DTAT research programme, plus
tools for trialists to design and simulate a '3+3/PC' dose-finding study.
Please see Norris (2017)